Holds one active US DMF for cysteamine, filing since 2018. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 30 markets.
Holds one active US DMF for cysteamine, filing since 2022. Its 2024 FDA inspection closed as VAI, and its GMP is recognised in 19 markets.
Holds 2 active US DMFs for cysteamine, filing since 2019. Its 2022 FDA inspection closed as VAI, and its GMP is recognised in 15 markets.
Holds one active US DMF for cysteamine, filing since 2022. Its 2024 FDA inspection closed as NAI, and its GMP is recognised in 2 markets.
Holds 4 active US DMFs for cysteamine, filing since 1992. Its 2022 FDA inspection closed as NAI, and its GMP is recognised in 1 market.
Holds 2 active US DMFs for cysteamine, filing since 2021. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 1 market.
Holds 2 active US DMFs for cysteamine, filing since 2013.
The names are listed below. Ask Fred about the filings, inspection history and GMP certificates on record for each manufacturer.
Chat with Fred, your AI analystContract manufacturers make to order rather than holding their own filing for this molecule.
The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Every factor appears on the card it produced. Read the full method.
Ask Fred which manufacturers are on record for cysteamine and what filings they hold.
Chat with Fred, your AI analyst